Skip to main content
Log in

Prognostic factors in stage IA–IIA cervical cancer patients treated surgically: does the waiting time to the operation affect survival?

  • Gynecologic Oncology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

This study aimed to identify prognostic factors in patients with stage IA–IIA cervical cancer who had undergone radical surgery and clarify whether the waiting time to the operation affected the recurrence and survival outcome.

Materials and methods

We retrospectively reviewed the records of 117 patients who underwent surgical resection for stage IA–IIA cervical cancer. Patients were subdivided based on the waiting time from the initial visit to a gynecologist until surgery. Univariate analyses were performed to evaluate factors associated with recurrence-free and overall survival.

Results

The mean time from the first visit to surgery was 48 days (range 20–92). Recurrence-free and overall survival rates were not affected by the waiting time to the operation. On univariate analysis, lymph node metastasis (p = 0.003) and lymph-vascular space invasion (p = 0.015) were prognostic predictors of progression-free survival, while the waiting time to the operation was not (p = 0.106). Lymph node metastasis (p = 0.007), lymph-vascular space invasion (p = 0.046), and the histological diagnosis (p = 0.027) were prognostic predictors of overall survival, but the waiting time to the operation was not (p = 0.653).

Conclusions

The waiting time to the operation from the initial visit to surgical intervention does not adversely affect the outcome of cervical cancer within the time frames analyzed in this study. Furthermore, surgery allows the status of the lymph nodes and lymph-vascular space invasion, dependent variables associated with survival, to be assessed accurately.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, Favini G, Ferri L, Mangioni C (1997) Randomised study of radical surgery versus radiotherapy for stage Ib–IIa cervical cancer. Lancet 350:535–540

    Article  PubMed  CAS  Google Scholar 

  2. Kirwan JM, Tincello DG, Herod JJ, Frost O, Kingston RE (2002) Effect of delays in primary care referral on survival of women with epithelial ovarian cancer: retrospective audit. BMJ 324:148–151

    Article  PubMed  Google Scholar 

  3. Crawford SC, Davis JA, Siddiqui NA, de Caestecker L, Gillis CR, Hole D, Penney G (2002) The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. BMJ 325:196

    Article  PubMed  Google Scholar 

  4. Position Statement, 2005. Canadian Society for Surgical Oncology. Available at http://www.cos.ca/csso. Accessed 30 June 2007

  5. Welcome to the Department of Health. Cancer waiting targets: a Guide, 2005. Department of Health, National Health Service. Available at http://www.dh.gov.uk. Accessed 30 June 2007

  6. Christensen ED, Harvald T, Jendresen M, Aggestrup S, Petterson G (1997) The impact of delayed diagnosis of lung cancer on the stage at the time of operation. Eur J Cardiothorac Surg 12:880–884

    Article  PubMed  CAS  Google Scholar 

  7. Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD (1999) The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer 79:858–864

    Article  PubMed  CAS  Google Scholar 

  8. Porta M, Gallen M, Malats N, Planas J (1991) Influence of “diagnostic delay” upon cancer survival: an analysis of five tumour sites. J Epidemiol Community Health 45:225–230

    Article  PubMed  CAS  Google Scholar 

  9. Sainsbury R, Johnston C, Haward B (1999) Effect on survival of delays in referral of patients with breast-cancer symptoms: a retrospective analysis. Lancet l 353:1132–1135

    Article  CAS  Google Scholar 

  10. Raptis DA, Fessas C, Belasyse-Smith P, Kurzawinski TR. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer. Surgeon 8:239–246

  11. Stec AA, Coons BJ, Chang SS, Cookson MS, Herrell SD, Smith JA Jr, Clark PE (2008) Waiting time from initial urological consultation to nephrectomy for renal cell carcinoma––does it affect survival? J Urol 179:2152–2157

    Article  PubMed  Google Scholar 

  12. Viswanathan AN, Deavers MT, Jhingran A, Ramirez PT, Levenback C, Eifel PJ (2004) Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol 93:27–33

    Article  PubMed  CAS  Google Scholar 

  13. Crowder S, Tuller E (2007) Small cell carcinoma of the female genital tract. Semin Oncol 34:57–63

    Article  PubMed  CAS  Google Scholar 

  14. Chan JK, Loizzi V, Burger RA, Rutgers J, Monk BJ (2003) Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis. Cancer 97:568–574

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that there are no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tomokazu Umezu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Umezu, T., Shibata, K., Kajiyama, H. et al. Prognostic factors in stage IA–IIA cervical cancer patients treated surgically: does the waiting time to the operation affect survival?. Arch Gynecol Obstet 285, 493–497 (2012). https://doi.org/10.1007/s00404-011-1966-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-011-1966-y

Keywords

Navigation